Matches in SemOpenAlex for { <https://semopenalex.org/work/W2097537105> ?p ?o ?g. }
- W2097537105 endingPage "773" @default.
- W2097537105 startingPage "765" @default.
- W2097537105 abstract "BackgroundWe assessed prevalences of seven sexually transmitted infections (STIs) in Peru, stratified by risk behaviours, to help to define care and prevention priorities.MethodsIn a 2002 household-based survey of the general population, we enrolled randomly selected 18–29-year-old residents of 24 cities with populations greater than 50 000 people. We then surveyed female sex workers (FSWs) in these cities. We gathered data for sexual behaviour; vaginal specimens or urine for nucleic acid amplification tests for Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; and blood for serological tests for syphilis, HIV, and (in subsamples) herpes simplex virus 2 (HSV2) and human T-lymphotropic virus. This study is a registered component of the PREVEN trial, number ISRCTN43722548.Findings15 261 individuals from the general population and 4485 FSWs agreed to participate in our survey. Overall prevalence of infection with HSV2, weighted for city size, was 13·5% in men, 13·6% in women, and 60·6% in FSWs (all values in FSWs standardised to age composition of women in the general population). The prevalence of C trachomatis infection was 4·2% in men, 6·5% in women, and 16·4% in FSWs; of T vaginalis infection was 0·3% in men, 4·9% in women, and 7·9% in FSWs; and of syphilis was 0·5% in men, 0·4% in women, and 0·8% in FSWs. N gonorrhoeae infection had a prevalence of 0·1% in men and women, and of 1·6% in FSWs. Prevalence of HIV infection was 0·5% in men and FSWs, and 0·1% in women. Four (0·3%) of 1535 specimens were positive for human T-lymphotropic virus 1. In men, 65·0% of infections with HIV, 71·5% of N gonorrhoeae, and 41·4% of HSV2 and 60·9% of cases of syphilis were in the 13·3% who had sex with men or unprotected sex with FSWs in the past year. In women from the general population, 66·7% of infections with HIV and 16·7% of cases of syphilis were accounted for by the 4·4% who had been paid for sex by any of their past three partners.InterpretationDefining of high-risk groups could guide targeting of interventions for communicable diseases—including STIs—in the general Peruvian population.FundingWellcome Trust-Burroughs Wellcome Fund Infectious Disease Initiative and US National Institutes of Health. We assessed prevalences of seven sexually transmitted infections (STIs) in Peru, stratified by risk behaviours, to help to define care and prevention priorities. In a 2002 household-based survey of the general population, we enrolled randomly selected 18–29-year-old residents of 24 cities with populations greater than 50 000 people. We then surveyed female sex workers (FSWs) in these cities. We gathered data for sexual behaviour; vaginal specimens or urine for nucleic acid amplification tests for Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; and blood for serological tests for syphilis, HIV, and (in subsamples) herpes simplex virus 2 (HSV2) and human T-lymphotropic virus. This study is a registered component of the PREVEN trial, number ISRCTN43722548. 15 261 individuals from the general population and 4485 FSWs agreed to participate in our survey. Overall prevalence of infection with HSV2, weighted for city size, was 13·5% in men, 13·6% in women, and 60·6% in FSWs (all values in FSWs standardised to age composition of women in the general population). The prevalence of C trachomatis infection was 4·2% in men, 6·5% in women, and 16·4% in FSWs; of T vaginalis infection was 0·3% in men, 4·9% in women, and 7·9% in FSWs; and of syphilis was 0·5% in men, 0·4% in women, and 0·8% in FSWs. N gonorrhoeae infection had a prevalence of 0·1% in men and women, and of 1·6% in FSWs. Prevalence of HIV infection was 0·5% in men and FSWs, and 0·1% in women. Four (0·3%) of 1535 specimens were positive for human T-lymphotropic virus 1. In men, 65·0% of infections with HIV, 71·5% of N gonorrhoeae, and 41·4% of HSV2 and 60·9% of cases of syphilis were in the 13·3% who had sex with men or unprotected sex with FSWs in the past year. In women from the general population, 66·7% of infections with HIV and 16·7% of cases of syphilis were accounted for by the 4·4% who had been paid for sex by any of their past three partners. Defining of high-risk groups could guide targeting of interventions for communicable diseases—including STIs—in the general Peruvian population." @default.
- W2097537105 created "2016-06-24" @default.
- W2097537105 creator A5023204827 @default.
- W2097537105 creator A5038221052 @default.
- W2097537105 creator A5040963030 @default.
- W2097537105 creator A5052792225 @default.
- W2097537105 creator A5052913420 @default.
- W2097537105 creator A5069424430 @default.
- W2097537105 date "2012-10-01" @default.
- W2097537105 modified "2023-10-16" @default.
- W2097537105 title "Prevalences of sexually transmitted infections in young adults and female sex workers in Peru: a national population-based survey" @default.
- W2097537105 cites W1985339853 @default.
- W2097537105 cites W1987389370 @default.
- W2097537105 cites W1995283362 @default.
- W2097537105 cites W1995950582 @default.
- W2097537105 cites W1997004947 @default.
- W2097537105 cites W1998931806 @default.
- W2097537105 cites W2007914086 @default.
- W2097537105 cites W2010455950 @default.
- W2097537105 cites W2018290901 @default.
- W2097537105 cites W2019506128 @default.
- W2097537105 cites W2021742467 @default.
- W2097537105 cites W2064095611 @default.
- W2097537105 cites W2072530299 @default.
- W2097537105 cites W2080338708 @default.
- W2097537105 cites W2086146731 @default.
- W2097537105 cites W2097405924 @default.
- W2097537105 cites W2121010704 @default.
- W2097537105 cites W2125042579 @default.
- W2097537105 cites W2133241248 @default.
- W2097537105 cites W2138155614 @default.
- W2097537105 cites W2139313213 @default.
- W2097537105 cites W2144178526 @default.
- W2097537105 cites W2151210540 @default.
- W2097537105 cites W2153938689 @default.
- W2097537105 cites W2157615258 @default.
- W2097537105 cites W2161223124 @default.
- W2097537105 cites W64368084 @default.
- W2097537105 doi "https://doi.org/10.1016/s1473-3099(12)70144-5" @default.
- W2097537105 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3459082" @default.
- W2097537105 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22878023" @default.
- W2097537105 hasPublicationYear "2012" @default.
- W2097537105 type Work @default.
- W2097537105 sameAs 2097537105 @default.
- W2097537105 citedByCount "84" @default.
- W2097537105 countsByYear W20975371052012 @default.
- W2097537105 countsByYear W20975371052013 @default.
- W2097537105 countsByYear W20975371052014 @default.
- W2097537105 countsByYear W20975371052015 @default.
- W2097537105 countsByYear W20975371052016 @default.
- W2097537105 countsByYear W20975371052017 @default.
- W2097537105 countsByYear W20975371052018 @default.
- W2097537105 countsByYear W20975371052019 @default.
- W2097537105 countsByYear W20975371052020 @default.
- W2097537105 countsByYear W20975371052021 @default.
- W2097537105 countsByYear W20975371052022 @default.
- W2097537105 countsByYear W20975371052023 @default.
- W2097537105 crossrefType "journal-article" @default.
- W2097537105 hasAuthorship W2097537105A5023204827 @default.
- W2097537105 hasAuthorship W2097537105A5038221052 @default.
- W2097537105 hasAuthorship W2097537105A5040963030 @default.
- W2097537105 hasAuthorship W2097537105A5052792225 @default.
- W2097537105 hasAuthorship W2097537105A5052913420 @default.
- W2097537105 hasAuthorship W2097537105A5069424430 @default.
- W2097537105 hasBestOaLocation W20975371051 @default.
- W2097537105 hasConcept C144024400 @default.
- W2097537105 hasConcept C149923435 @default.
- W2097537105 hasConcept C203014093 @default.
- W2097537105 hasConcept C2776983459 @default.
- W2097537105 hasConcept C2777391075 @default.
- W2097537105 hasConcept C2778082588 @default.
- W2097537105 hasConcept C2779166590 @default.
- W2097537105 hasConcept C2780122209 @default.
- W2097537105 hasConcept C2781114625 @default.
- W2097537105 hasConcept C2908647359 @default.
- W2097537105 hasConcept C2909760446 @default.
- W2097537105 hasConcept C29456083 @default.
- W2097537105 hasConcept C3013748606 @default.
- W2097537105 hasConcept C71924100 @default.
- W2097537105 hasConcept C86803240 @default.
- W2097537105 hasConcept C89423630 @default.
- W2097537105 hasConcept C99454951 @default.
- W2097537105 hasConceptScore W2097537105C144024400 @default.
- W2097537105 hasConceptScore W2097537105C149923435 @default.
- W2097537105 hasConceptScore W2097537105C203014093 @default.
- W2097537105 hasConceptScore W2097537105C2776983459 @default.
- W2097537105 hasConceptScore W2097537105C2777391075 @default.
- W2097537105 hasConceptScore W2097537105C2778082588 @default.
- W2097537105 hasConceptScore W2097537105C2779166590 @default.
- W2097537105 hasConceptScore W2097537105C2780122209 @default.
- W2097537105 hasConceptScore W2097537105C2781114625 @default.
- W2097537105 hasConceptScore W2097537105C2908647359 @default.
- W2097537105 hasConceptScore W2097537105C2909760446 @default.
- W2097537105 hasConceptScore W2097537105C29456083 @default.
- W2097537105 hasConceptScore W2097537105C3013748606 @default.
- W2097537105 hasConceptScore W2097537105C71924100 @default.
- W2097537105 hasConceptScore W2097537105C86803240 @default.
- W2097537105 hasConceptScore W2097537105C89423630 @default.